Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Dany, Grahek"'
Autor:
Khaldoun Kerrou, Dany Grahek, Michael Soussan, Françoise Montravers, Valérie Nataf, Jean-Noël Talbot, Odile Pascal
Publikováno v:
Nuclear Medicine Communications. 33:775-779
The aim of this study was to determine whether early acquisition of F-fluorodihydroxyphenylalanine (F-FDOPA) PET/CT could improve the detection of medullary thyroid cancer (MTC). We retrospectively compared early (median time: 15 min) and delayed (me
Autor:
Dany Grahek, Jean-Noël Talbot, P. El Chater, J. Lacau St Guily, Sona Balogova, B. Susini, Khaldoun Kerrou, Françoise Montravers, Sophie Périé, B. Angelard
Publikováno v:
Molecular Imaging and Biology. 10:364-373
The clinical usefulness of 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography (FDG-PET) in head and neck squamous cell carcinoma (HNSCC) is now well-documented. However, its sensitivity is greater than its specificity due to false-positive
Autor:
Emmanuel Touboul, Philippe Ruszniewski, Khaldoun Kerrou, Dany Grahek, Jean-Didier Grangé, Fabrice Gutman, Françoise Montravers, Philippe Rougier, Houry S, Raoul Poupon, Thierry André, Jean-Noël Talbot, Olivier Rosmorduc, Virginie Huchet
Publikováno v:
La Presse Médicale. 37:e1-e24
In digestive oncology, the most frequent indication for FDG PET, in our experience and as reported in the literature, is the localisation of recurrent colorectal cancer. This molecular imaging method has also been shown to be clinically useful in var
Autor:
Fabrice Gutman, Olivier Cussenot, Virginie Huchet, Dany Grahek, Khaldoun Kerrou, Sona Balogova, Jean-Noël Talbot, Françoise Montravers, B. Gattegno, Philippe Thibault, Nacer Kerrouche
Publikováno v:
La Presse Médicale. 36:1794-1806
In prostate cancer, use of FDG, the radiopharmaceutical currently most widely used in oncology, is limited to the most aggressive cancers and, in the absence of another tracer, to attempting to localise occult recurrences detected biochemically (elev
Autor:
Khaldoun Kerrou, Fabrice Gutman, S. Balogova, Dany Grahek, R. Assad, Virginie Huchet, Jean-Noël Talbot, V. Bizien, Françoise Montravers, S. Derhy, Valérie Nataf
Publikováno v:
Médecine Nucléaire. 31:338-344
Resume Cet article illustre, a l’aide du cas de trois patients examines a l’hopital Tenon, l’aide potentielle de la TEP/TDM a la fluoromethycholine-(18F) (FCH) dans trois circonstances de recidive de cancer de la prostate : recidive precoce ou
Autor:
Dany Grahek, Khaldoun Kerrou, Vanessa Aflalo-Hazan, Fabrice Gutman, Françoise Montravers, Jean-Noël Talbot
Publikováno v:
American Journal of Roentgenology. 187:W618-W621
Autor:
Dany Grahek, Jean Lacau Saint Guily, Sophie Périé, Françoise Montravers, Khaldoun Kerrou, Fabrice Gutman, Étienne Roulet, Jean-Noël Talbot
Publikováno v:
La Presse Médicale. 35:1371-1376
Points essentiels La TEP au FDG peut permettre de localiser le cancer primitif lorsqu’une metastase a ete decouverte sans que la lesion primitive ne soit mise en evidence par la clinique, la biologie (dosage des marqueurs tumoraux, etc.) ou l’ima
Autor:
Khaldoun Kerrou, Fabrice Gutman, Paolo Zanotti, Françoise Duron, Jean Lacau Saint Guily, Sophie Périé, N. Younsi, Françoise Montravers, Gérard Maurel, Jean Yves Devaux, Jean-Noël Talbot, Dany Grahek
Publikováno v:
La Presse Médicale. 35:1377-1385
FDG PET can detect thyroid cancer in patients referred for exploration of a different cancer. Because of its lack of specificity, however, this modality is not indicated for examination of thyroid nodules: ultrasonography and fine needle biopsy with
Autor:
Dany Grahek, Nathalie Cailleux, Jean-Noël Talbot, Fabrice Gutman, Françoise Montravers, Khaldoun Kerrou
Publikováno v:
La Presse Médicale. 35:1339-1346
FDG, a radioactive glucose analog for PET imaging, requires some precautions: it should be used only in patients with glycemia < 7mmol/L, fasting for at least 6 h but well hydrated, and after pregnancy is ruled out. FDG-PET has many indications in on
Autor:
Nicolas Gault, Dany Grahek, Khaldoun Kerrou, Françoise Montravers, Fabrice Gutman, Michel Schlienger, Jean-Noël Talbot, Emmanuel Touboul
Publikováno v:
La Presse Médicale. 35:1347-1353
Points essentiels La biodistribution normale du FDG comporte une importante activite physiologique dans le cerveau dont le glucose constitue l’aliment principal. La detection des foyers neoplasiques qui accumulent le FDG est donc difficile du fait